Kantify, a computational biotech company specializing in AI-powered small molecule and protein degrader discovery, is excited to announce its selection to pitch at the Tech.eu 2023 Summit in Brussels, happening on May 24.

The Tech.eu Summit is a highly anticipated event that unites the best startups, investors, and industry experts from across Europe. It provides a platform for sharing innovative ideas and driving forward the future of technology.

As an organization driven by a mission to save lives using AI for good, Kantify is honored to have the opportunity to showcase our groundbreaking technology at the Tech.eu Summit. Our AI-powered solutions have the potential to revolutionize drug discovery and positively impact society.

We look forward to connecting with investors, industry leaders, and potential partners who share our vision of harnessing the power of AI for transformative advancements. This invitation to pitch validates the hard work and expertise of our exceptional team, and we are eager to share our passion for accelerating drug discovery processes.

Stay tuned as we provide updates on our journey at the Tech.eu Summit. Together, we can leverage AI to make a difference in the world and improve the lives of countless individuals.